Endologix Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
132,257.00
147,588.00
153,612.00
192,925.00
181,157.00
Cost of Goods Sold (COGS) incl. D&A
33,050.00
41,801.00
51,821.00
69,133.00
59,828.00
Gross Income
99,207.00
105,787.00
101,791.00
123,792.00
121,329.00
SG&A Expense
109,575.00
134,933.00
150,233.00
197,355.00
161,672.00
EBIT
10,368.00
29,146.00
-
73,563.00
40,343.00
Unusual Expense
8,500.00
7,928.00
5,171.00
62,842.00
5,089.00
Non Operating Income/Expense
3,061.00
5,798.00
1,153.00
2,161.00
554.00
Interest Expense
321.00
5,709.00
7,476.00
15,841.00
22,064.00
Pretax Income
16,078.00
32,480.00
59,761.00
154,179.00
66,859.00
Income Tax
10.00
62.00
9,337.00
498.00
459.00
Consolidated Net Income
16,068.00
32,418.00
50,424.00
154,677.00
66,400.00
Net Income
16,068.00
32,418.00
50,424.00
154,677.00
66,400.00
Net Income After Extraordinaries
16,068.00
32,418.00
50,424.00
154,677.00
66,400.00
Net Income Available to Common
16,068.00
32,418.00
50,424.00
154,677.00
66,400.00
EPS (Basic)
0.26
0.50
0.75
1.91
0.80
Basic Shares Outstanding
62,607.00
65,225.00
67,671.00
80,976.00
83,325.00
EPS (Diluted)
0.26
0.50
0.75
1.91
0.80
Diluted Shares Outstanding
62,607.00
65,225.00
67,671.00
80,976.00
83,325.00
EBITDA
8,017.00
25,863.00
42,556.00
64,414.00
31,232.00
Non-Operating Interest Income
50.00
245.00
175.00
228.00
83.00

About Endologix

View Profile
Address
2 Musick
Irvine California 92618
United States
Employees -
Website http://www.endologix.com
Updated 09/14/2018
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.